Myomo, Inc. Net Change in Cash
Myomo, Inc. (MYO) reported Net Change in Cash of -$2.91 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-05
- Myomo, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$2.74M.
- Myomo, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$4.58M.
- Myomo, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$1.44M, a 136.67% decline year-over-year.
- Myomo, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was $3.92M.
- Myomo, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$10.04M, a 156.17% decline from fiscal 2024.
- Myomo, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was $17.88M, a 1071.94% increase from fiscal 2023.
- Myomo, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $1.53M.
- Myomo, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$10.18M, a 410.02% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.91M 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | -$2.74M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$10.04M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | -$11.82M 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | -$10.13M 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | -$4.58M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $17.88M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $126.37K 10-Q · filed 2025-11-10 | |||
| 2024-06-30 | -$1.03M 10-Q · filed 2025-08-11 | |||
| 2024-03-31 | -$1.44M 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $1.53M 10-K · filed 2025-03-10 | |||
| 2023-09-30 | $1.57M 10-Q · filed 2024-11-06 | |||
| 2023-06-30 | $660.32K 10-Q · filed 2024-08-06 | |||
| 2023-03-31 | $3.92M 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$10.18M 10-K · filed 2024-03-08 | |||
| 2022-09-30 | -$8.10M 10-Q · filed 2023-11-07 | |||
| 2022-06-30 | -$5.29M 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | -$2.58M 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $3.28M 10-K · filed 2023-03-13 | |||
| 2021-09-30 | $365.50K 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $1.53M 10-Q · filed 2022-08-03 | |||
| 2021-03-31 | $5.13M 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | $7.70M 10-K · filed 2022-03-11 | |||
| 2020-09-30 | $8.85M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $6.27M 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | $9.26M 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | -$2.08M 10-K · filed 2021-03-10 | |||
| 2019-09-30 | -$2.21M 10-Q · filed 2020-11-10 | |||
| 2019-06-30 | $128.08K 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $2.69M 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | -$6.40M 10-K · filed 2020-03-13 | |||
| 2018-09-30 | -$3.84M 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | -$1.25M 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | $1.16M 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | $12.16M 10-K · filed 2019-03-12 | |||
| 2017-09-30 | $4.16M 10-Q · filed 2018-11-07 | |||
| 2017-06-30 | $6.31M 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B |